76
Views
0
CrossRef citations to date
0
Altmetric
Original Research

A case of cholestatic hepatitis associated with histologic features of acute cholangitis

, , , , , , & show all
Pages 793-798 | Published online: 23 Nov 2011

References

  • LeeWMDrug-induced hepatotoxicityN Engl J Med2003349547448512890847
  • TakikawaHRecent status of drug-induced liver injury and its problems in JapanJMAJ2010534243247
  • BénichouCCriteria of drug-induced hepatic disorders. Report of an international consensus meetingJ Hepatol19901122722762254635
  • AndradeRJLucenaMIFernándezMCDrug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year periodGastroenterology2005129251252116083708
  • PapayJIClinesDRafiRDrug-induced liver injury following positive drug rechallengeRegul Toxicol Pharmacol2000541849019303041
  • HuntCMMitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic reviewHepatology20015262216222221105110
  • CasaliAMSiringoSSofiaSBolondiLDi FeboGCavalliGQuantitative analysis of intrahepatic bile duct component in normal adult human liver and in primary biliary cirrhosisPathol Res Pract199419022012068058574
  • TakikawaHRecent status of drug-induced liver injuryHepatol Res20093911618637144
  • TanimotoHNomuraHA case of bisferiens fluctuation associated with unknown acute liver injuryJapanese Journal of Clinical and Experimental Medicine200986110111 Japanese
  • RussmannSJetterAKullak-UblickGAPharmacogenetics of drug- induced liver injuryHepatology201052274876120607838
  • JaeschkeHGoresGJCederbaumAIHinsonJAPessayreDLemastersJJMechanisms of hepatotoxicityToxicol Sci200265216617611812920
  • ManyikePTKharaschEDKalhornTFSlatteryJTContribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formationClin Pharmacol Ther200067327528210741631
  • LeSageGDGlaserSSMarucciLAcute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liverAm J Physiol19992765 Pt 1G1289G130110330021
  • SwankLAChejfecGNemchauskyBAAllopurinol-induced granulomatous hepatitis with cholangitis and a sarcoid-like reactionArch Intern Med19781386997998646570
  • LarreyDHadengueAPessayreDChoudatLDeGottCBenhamouJPCarbamazepine-induced acute cholangitisDig Dis Sci19873255545573568943
  • MyersJLAugurNAJrHydralazine-induced cholangitisGastroenterology1984875118511886479540
  • LercheAVybergMKirkegaardEAcute cholangitis and pancreatitis associated with sulindac (clinoril)Histopathology19871166476533623432
  • ChungWHHungSIChenYTHuman leukocyte antigens and drug hypersensitivityCurr Opin Allergy Clin Immunol20077431732317620823
  • HautekeeteMLHorsmansYVan WaeyenbergeCHLA association of amoxicillin–clavulanate-induced hepatitisGastroenterology199911751181118610535882
  • ReauNSJensenDMVanishing bile duct syndromeClin Liver Dis200812120321718242505
  • ClyneBOlshakerJSThe C-reactive proteinJ Emerg Med19991761019102510595891
  • BénichouCDananGFlahaultACausality assessment of adverse reactions to drugs – II. Original model for validation of drug causality assessment methods: case reports with positive rechallengeJ Clin Epidemiol19934611133113368229111
  • LoperfidoSAngeliniGBenedettiGMajor early complications from diagnostic and therapeutic ERCP: a prospective multicenter studyGastrointest Endosc1998481109684657
  • HarrisonRFPatsiaouraKHubscherSGCytokeratin immunostaining for detection of biliary epithelium: its use in counting bile ducts in cases of liver allograft rejectionJ Clin Pathol19944743033087517955